COMPANY
MultiValent Biotherapies
Funding and NIH signals
- SEC Form D raise Raised $10.01M (Form D filed Mar 2, 2026); +1 other Form D filing in the last 12 months. SEC Form D 0002107846-26-000002 (Mar 2, 2026)
Evidence (2 events)
- Mar 2, 2026 · SEC Form D 0002107846-26-000002
Name of Issuer: MultiValent Biotherapies, Inc.; CIK: 2107846; Address: Los Altos, CA; Submission type: D; Filing date: 2026-03-02; Industry Group: Biotechnology; Date of First Sale: 2026-01-09; Types of Securities Offered: Equity, Debt; Business combination transaction: false; Total Offering Amount: Indefinite; Total Amount Sold: 10012500; Federal exemptions: 06b - Feb 27, 2026 · SEC Form D 0002107846-26-000001
Name of Issuer: MultiValent Biotherapies, Inc.; CIK: 2107846; Address: Los Altos, CA; Submission type: D; Filing date: 2026-02-27; Industry Group: Biotechnology; Date of First Sale: 2026-01-05; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 4375; Total Amount Sold: 4375; Federal exemptions: 06b
- Mar 2, 2026 · SEC Form D 0002107846-26-000002